Clinical Trials Directory

Trials / Completed

CompletedNCT01148771

Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion

Comparative Pharmacokinetics, Safety, and Pharmacodynamics of Ertapenem 1 Gram Daily Administered as an IV Bolus Versus Standard 30 Minute Infusion to Healthy Adult Volunteers

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Hartford Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to characterize and compare the concentration-time profiles and multiple dose pharmacokinetics of a 5 minute intravenous (IV) bolus of ertapenem 1 gram daily versus the standard 30 minute infusion in healthy volunteers. Safety and tolerability and pharmacodynamic target attainment using Monte Carlo simulation will also be assessed and compared.

Conditions

Interventions

TypeNameDescription
DRUGertapenem1 gram IV bolus every 24 hours (q24h) for 3 days
DRUGertapenem1 gram 30 minute infusion q24h for 3 days

Timeline

Start date
2010-08-01
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2010-06-22
Last updated
2012-05-11
Results posted
2012-05-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01148771. Inclusion in this directory is not an endorsement.

Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion (NCT01148771) · Clinical Trials Directory